These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18301833)

  • 1. Agranulocytosis monitoring with Clozapine patients: to follow guidelines or to attempt therapeutic controversies?
    Chandrasekaran PK
    Singapore Med J; 2008 Feb; 49(2):96-9. PubMed ID: 18301833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine-associated agranulocytosis: risk and aetiology.
    Krupp P; Barnes P
    Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
    McKee JR; Wall T; Owensby J
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematological side effects of clozapine: patient characteristics.
    Miller PR; Cutten AE
    N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
    Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
    N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia, drug therapy, and monitoring.
    Bradford DW; Stroup TS
    N Engl J Med; 2004 Jan; 350(4):415-6. PubMed ID: 14736938
    [No Abstract]   [Full Text] [Related]  

  • 10. Clozapine: balancing safety with superior antipsychotic efficacy.
    Meltzer HY
    Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):134-44. PubMed ID: 23006238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine: a novel antipsychotic with a controversial introduction.
    Ogle MR; Miller MJ
    Indiana Med; 1991 Sep; 84(9):606-10. PubMed ID: 1682361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased use of antibiotics in patients treated with clozapine.
    Nielsen J; Foldager L; Meyer JM
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):483-6. PubMed ID: 19356909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
    Güzelcan Y; Scholte WF
    Tijdschr Psychiatr; 2006; 48(4):295-302. PubMed ID: 16955993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clozapine screening: white bloodcell counts no longer sufficient].
    Cohen D;
    Tijdschr Psychiatr; 2010; 52(11):785-90. PubMed ID: 21064021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.
    Schulte P
    Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time for a change to clozapine haematological monitoring.
    Cheng A; Buten S; Large M
    Australas Psychiatry; 2024 Aug; 32(4):342-345. PubMed ID: 38820548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
    Maskasame S; Krisanaprakornkit T; Khiewyoo J
    J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine alone versus clozapine and risperidone for refractory schizophrenia.
    Gerson SL
    N Engl J Med; 2006 Apr; 354(17):1846-8; author reply 1846-8. PubMed ID: 16642587
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.